Low Grade Glioma (LGG) of Brain With BRAF Aberration

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Low Grade Glioma (LGG) of Brain With BRAF Aberration trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Active — Not RecruitingPhase 1/2

NCT04201457

A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration

This phase I/II trial is designed to study the side effects, best dose and efficacy of adding hydroxychloroquine to dabrafenib and/or trametinib in children wit…

United States57 participantsStarted 2020-01-17

Treatment: Dabrafenib, Trametinib